Tag:
4SC AG
Latest Headlines
Latest Headlines
4SC surges on positive midstage data for advanced liver cancer
Shares of Germany's 4SC ( $VSC ) surged 35% after investigators reported promising mid-stage data for the cancer drug resminostat, an HDAC inhibitor, in difficult-to-treat patients with advanced liver
Germany's 4SC misses mark in key RA drug trial, CEO keeps faith
Falling short of its primary goal in a mid-stage study for an oral drug in rheumatoid arthritis patients, German biotech 4SC ( $VSC ) is keeping its chin up in pursuit of a partner to take the
German contender chases Pfizer in oral RA drug pursuit
Pfizer ( $PFE ) isn't alone in the hunt to develop an oral rheumatoid arthritis drug. German biotech 4SC is attracting some attention for its experimental pill that could eventually capture a chunk of
